Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the therapeutic benefit and safety of subcutaneous (SC) Surovatamig monotherapy as consolidation therapy in patients with Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) with unmutated IGHV (uIGHV).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza białaczki limfocytowej lub chłoniaka limfocytowego z określoną strukturą genetyczną
- •Wcześniejsze leczenie pierwszej linii z dobrym wynikiem
- •U pacjentów z chłoniakiem musi być widoczna choroba na badaniach
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu
- •Prawidłowe wyniki badań krwi, wątroby, nerek i serca
- •Kobiety muszą stosować skuteczną antykoncepcję
- •Mężczyźni sexualnie aktywni muszą stosować prezerwatywy
✗ Disqualifies
- •Transformacja choroby w bardziej agresywną postać nowotworu
- •Zajęcie układu nerwowego przez nowotwór
- •Historia zakaźnego zapalenia mózgu typu progresywnego
- •Inny nowotwór w przeszłości lub obecny
- •Aktywna lub niekontrolowana infekcja
- •Zakażenie HIV lub przewlekłe zakaźenie wsiami B lub C
- •Poważne problemy z sercem
- •Uczulenie na surovatamig
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 18 Years
- Last updated (source)
- July 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (30)
Research Site
Adelaide, Australia
Research Site
Fitzroy, Australia
Research Site
Heidelberg, Australia
Research Site
Nedlands, Australia
Research Site
Perth, Australia
Research Site
Rockingham, Australia
Research Site
Calgary, Canada
Research Site
Vancouver, Canada
Research Site
Halifax, Canada
Research Site
Hamilton, Canada
Research Site
Toronto, Canada
Research Site
Montreal, Canada
Research Site
Montreal, Canada
Research Site
Québec, Canada
Research Site
Adapazarı, Turkey (Türkiye)
Research Site
Antalya, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Kocaeli, Turkey (Türkiye)
Research Site
Mezitli, Turkey (Türkiye)
Research Site
Edinburgh, United Kingdom
Research Site
Hampshire, United Kingdom
Research Site
Leeds, United Kingdom
Research Site
London, United Kingdom
Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom
Research Site
Nottingham, United Kingdom
Research Site
Oxford, United Kingdom
Research Site
Sutton, United Kingdom
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.